Abstract N6‑methyladenosine (m6A) is the most prevalent and abundant type of internal post‑
transcriptional RNA modification in eukaryotic cells. Multiple types of RNA, including …

Abstract These Society for Vascular Surgery Clinical Practice Guidelines describe the care
of patients with aneurysms of the visceral arteries. They include evidence-based size …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …

Peripheral artery disease is an atherosclerotic disease of the lower extremities associated
with high cardiovascular mortality. Management of this condition may include lifestyle …

Prostanoids are bioactive lipid mediators and take part in many physiological and
pathophysiological processes in practically every organ, tissue and cell, including the …

Peripheral artery disease (PAD) is a manifestation of atherosclerosis in the leg arteries,
which causes claudication. This may be in part due to vascular mitochondrial dysfunction …

Background Underuse of guideline‐recommended therapy in peripheral artery disease
(PAD) in administrative and procedural databases has been described, but reports on …

Abdominal aortic aneurysm (AAA) is a chronic vascular degenerative disease featured by
progressive dilation and remodeling of the vascular wall, which may lead to aortic rupture …

Cardiac rehabilitation (CR) is an important component in the continuum of care for patients
with cardiovascular diseases, including the older population. Benefits of CR which include …

OBJECTIVE. Although radiologists developed endovascular treatment of peripheral arterial
disease (PAD) in the 1960s, vascular surgeons and cardiologists have become increasingly …